10/09/2019
10:46 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2019
3:18 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2019
3:15 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
10/01/2019
3:32 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
3:28 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
3:26 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
10/01/2019
1:23 PM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
09/25/2019
4:31 PM | OAKTREE CAPITAL MANAGEMENT LP (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
09/23/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2019
5:06 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2019
4:19 PM | Sorrento Therapeutics (Filer)
| Form DEF 14A
| |
08/14/2019
12:39 PM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
08/12/2019
9:10 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2019
9:07 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
3:49 PM | Sorrento Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2019
3:49 PM | Sorrento Therapeutics (Filer)
| Form PRE 14A
| |
07/02/2019
11:52 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2019
11:15 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
07/01/2019
3:53 PM | Sorrento Therapeutics (Filer)
| Form 424B3
| |
06/28/2019
4:20 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
06/28/2019
4:17 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
5:06 AM | Sorrento Therapeutics (Subject)
| Form FWP
| |
06/28/2019
5:06 AM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
06/20/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2019
3:40 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2019
3:28 PM | Sorrento Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/17/2019
8:22 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2019
3:46 PM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
06/05/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2019
4:07 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2019
4:00 PM | Sorrento Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2019
9:41 AM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
05/13/2019
3:02 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
3:01 PM | Sorrento Therapeutics (Filer)
| Form NT 10-Q
| |
05/09/2019
4:14 PM | Opko Health, Inc. (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13D
| |
05/07/2019
11:15 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
05/07/2019
3:54 PM | Sorrento Therapeutics (Filer)
| Form 424B3
| |
05/03/2019
4:01 PM | Sorrento Therapeutics (Filer)
| Form S-3/A
| |
05/03/2019
3:01 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
8:17 PM | Sorrento Therapeutics (Filer)
| Form 10-K/A
| |
04/23/2019
8:03 PM | SHAH JAISIM (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
8:02 PM | Lemus David (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
8:02 PM | Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
8:01 PM | Ji Henry (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
8:00 PM | Followwill Dorman (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
8:00 PM | Sorrento Therapeutics (Issuer)
Wu Yue Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
7:59 PM | Shao Jiong (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2019
8:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2019
5:08 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2019
12:14 PM | Sorrento Therapeutics (Filer)
| Form 8-K/A
| |
04/03/2019
8:01 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2019
5:46 AM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
03/15/2019
5:30 AM | Sorrento Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2019
4:16 PM | Sorrento Therapeutics (Filer)
| Form NT 10-K
| |
02/13/2019
5:05 AM | Ally Bridge Group Capital Partners II, L.P. (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
02/11/2019
4:28 PM | Sorrento Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/23/2019
8:35 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2018
11:18 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
12/21/2018
3:51 PM | Sorrento Therapeutics (Filer)
| Form 424B3
| |
12/13/2018
5:12 AM | Asia Pacific MedTech Ltd (0001704813) (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
12/13/2018
5:10 AM | China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
12/13/2018
5:08 AM | Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
12/12/2018
8:30 PM | Sorrento Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/27/2018
6:49 PM | Sorrento Therapeutics (Issuer)
ZELDIS JEROME B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:49 PM | Shao Jiong (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:48 PM | Sorrento Therapeutics (Issuer)
Wu Yue Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:48 PM | SHAH JAISIM (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:47 PM | Lemus David (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:47 PM | Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:46 PM | Followwill Dorman (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
3:04 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2018
4:07 PM | Sorrento Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2018
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2018
3:12 PM | ABG II-SO Ltd (Reporting)
ABG Innovation-SO Ltd (Reporting)
ABG Management Ltd (Reporting)
ABG SRNE Ltd (Reporting)
Ally Bridge Group Capital Partners II, L.P. (Reporting)
Ally Bridge Group Innovation Capital Partners III, L.P. (Reporting)
Ally Bridge LB Healthcare Master Fund Ltd (Reporting)
Ally Bridge LB Management Ltd (Reporting)
Li Bin (Reporting)
Sorrento Therapeutics (Issuer)
Yu Fan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2018
3:41 PM | Sorrento Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/10/2018
5:03 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2018
5:03 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2018
4:21 PM | Sorrento Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2018
3:14 PM | Sorrento Therapeutics (Filer)
| Form DEFA14A
| |
07/23/2018
5:50 AM | Ji Henry (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2018
3:18 PM | Sorrento Therapeutics (Filer)
| Form DEFA14A
| |
07/19/2018
3:04 PM | Sorrento Therapeutics (Filer)
| Form DEF 14A
| |
07/13/2018
5:05 AM | Magnum Opus 2 International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
07/13/2018
5:02 AM | Magnum Opus 2 International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
07/09/2018
4:19 PM | Sorrento Therapeutics (Filer)
| Form PRER14A
| |
06/27/2018
4:04 PM | Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
06/27/2018
4:01 PM | Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
06/27/2018
4:00 PM | Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
06/22/2018
3:29 PM | Asia Pacific MedTech Ltd (0001704813) (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
06/22/2018
3:28 PM | China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
06/22/2018
3:27 PM | Sorrento Therapeutics (Subject)
Top Path Asia Ltd (Filed by)
| Form SC 13G
| |
06/22/2018
3:27 PM | Hongguo International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
06/22/2018
3:26 PM | China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
06/22/2018
3:23 PM | Sorrento Therapeutics (Subject)
Top Path Asia Ltd (Filed by)
| Form SC 13G
| |
06/22/2018
3:18 PM | Hongguo International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
